Health Law Matters

Trump Issues Executive Order to Improve Quality and Price Transparency

The Week In Health Law

  • President Trump issued an executive order directing multiple federal agencies to develop regulations with the goal of enhancing consumers’ ability to gain access to information on the quality and pricing of health care services.
  • The U.S. Department of Health and Human Services (“HHS”) was ordered to issue a proposed rule within 60 days “to require hospitals to publicly post standard charge information, including charges and information on negotiated rates and for common or shoppable items and services, in an easy-to-understand, consumer-friendly, and machine readable format.”
  • HHS and the Departments of Treasury and Labor were ordered to issue, within 90 days, an advance notice for public comments on requiring providers and insurers to disclose information about out-of-pocket costs before patients receive care. And within 180 days, HHS, along with the Departments of Defense and Veterans Affairs, are to develop a health quality roadmap to align and improve reporting on data and quality measures across federal health care programs.
  • The order also aims at granting researchers, innovators, and providers with access to de-identified claims data so they can develop tools for informing patients about prices and quality, as well as incentivizing consumers to shop for care by expanding the benefit of Health Savings Accounts and other tax-preferred health accounts. 

More trending Health Law topics this week:

  • Medtronic Recalls Insulin Pumps Based on Cybersecurity Fears

Post a comment:

*All fields are required.

Ask the Blogger

Do you have a topic that you would like discussed in a future blog article? Please let us know. If you have a confidential question regarding a blog article, please feel free to contact the article's author directly, or let us know if you would like for someone to contact you directly.

Attorney Spotlight

Brian F. Higgins is an associate in FBT's regulated business group with a focus on health care, and he has a history as corporate counsel to Medpace, Inc., a pharmaceutical clinical research organization.

Top